PMID: 11606195Oct 19, 2001Paper

The C-terminal fragment of the Alzheimer's disease amyloid protein precursor is degraded by a proteasome-dependent mechanism distinct from gamma-secretase

European Journal of Biochemistry
J NunanD H Small

Abstract

The beta-amyloid protein (Abeta) is derived by proteolytic processing of the amyloid protein precursor (APP). Cleavage of APP by beta-secretase generates a C-terminal fragment (APP-CTFbeta), which is subsequently cleaved by gamma-secretase to produce Abeta. The aim of this study was to examine the cleavage of APP-CTFbeta by gamma-secretase in primary cortical neurons from transgenic mice engineered to express the human APP-CTFbeta sequence. Neurons were prepared from transgenic mouse cortex and proteins labelled by incubation with [35S]methionine and [35S]cysteine. Labelled APP-CTFbeta and Abeta were then immunoprecipitated with a monoclonal antibody (WO2) specific for the transgene sequences. Approximately 30% of the human APP-CTFbeta (hAPP-CTFbeta) was converted to human Abeta (hAbeta), which was rapidly secreted. The remaining 70% of the hAPP-CTFbeta was degraded by an alternative pathway. The cleavage of hAPP-CTFbeta to produce hAbeta was inhibited by specific gamma-secretase inhibitors. However, treatment with proteasome inhibitors caused an increase in both hAPP-CTFbeta and hAbeta levels, suggesting that the alternative pathway was proteasome-dependent. A preparation of recombinant 20S proteasome was found to cleave a rec...Continue Reading

References

Jun 1, 1985·Proceedings of the National Academy of Sciences of the United States of America·C L MastersK Beyreuther
Nov 10, 1995·The Journal of Biological Chemistry·B L MartinB A Yankner
Mar 1, 1997·Journal of Neurochemistry·A C LeBlancC G Goodyer
Apr 1, 1997·Current Opinion in Structural Biology·W Baumeister, A Lupas
Aug 1, 1998·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·J G CulvenorR Cappai
Sep 29, 1999·Proceedings of the National Academy of Sciences of the United States of America·S Sinha, I Lieberburg
May 24, 2000·Proceedings of the National Academy of Sciences of the United States of America·D J Selkoe, M S Wolfe
Jun 15, 2000·Journal of Neurochemistry·J N KellerW R Markesbery
Aug 16, 2000·Proceedings of the National Academy of Sciences of the United States of America·Y A LamR Layfield
Aug 25, 2000·The Journal of Biological Chemistry·B D BennettR Vassar
Oct 18, 2000·FEBS Letters·J Nunan, D H Small

❮ Previous
Next ❯

Citations

Feb 3, 2009·Archives of Pharmacal Research·Hyun-Min ParkMi-Kyoung Kwak
Nov 26, 2002·Trends in Neurosciences·Frédéric Checler, Bruno Vincent
Oct 3, 2002·Journal of Neurochemistry·Della C DavidMaria Grazia Spillantini
Oct 20, 2009·Proceedings of the National Academy of Sciences of the United States of America·Kaushik GhosalSanjay W Pimplikar
Nov 15, 2008·The Journal of Biological Chemistry·Zen KouchiNikolaos K Robakis
Nov 10, 2006·Molecular Biology of the Cell·Thorsten MüllerRupert Egensperger
Jul 23, 2008·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Arek SzklarczykKatherine Conant
Nov 9, 2010·BMC Neuroscience·Jeremy H ToynCharles F Albright
Nov 26, 2013·Molecular and Cellular Neurosciences·Lotta AgholmeMartin Hallbeck
Mar 11, 2003·Proceedings of the National Academy of Sciences of the United States of America·Robert F Kalejta, Thomas Shenk
Jul 29, 2005·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·R C SmithJ Magrané
Oct 21, 2015·Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology·Saeed Sadigh-EteghadAlireza Majdi
Oct 26, 2011·Cellular Signalling·Caroline BeckettAnthony J Turner
Oct 25, 2006·Journal of Neurochemistry·Guiqiong HeWeihong Song
Sep 18, 2015·Neurochemical Research·Natalia N NalivaevaAnthony J Turner
Nov 12, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Yanuar Alan Sulistio, Klaus Heese
Mar 20, 2012·Journal of Enzyme Inhibition and Medicinal Chemistry·Tae-Kil EomSe-Kwon Kim
Apr 25, 2015·Biochemistry·Haizhi WangAleister Saunders
Feb 17, 2007·Biochemical and Biophysical Research Communications·Antje VoigtUlrike Kuckelkorn
Sep 19, 2006·Molecular and Cellular Neurosciences·Amy S EspesethDaria Hazuda
Feb 3, 2007·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Christine ClamagirandPaul Cohen
Mar 21, 2017·Biochemical and Biophysical Research Communications·Jun Ki JangIck Young Kim
Nov 5, 2003·Journal of Neuroscience Research·Geneviève EvinQiao-Xin Li
Apr 17, 2004·The Journal of Biological Chemistry·Didier Pitsi, Jean-Noël Octave
May 5, 2018·Journal of Cell Science·María Gabriela OteroTomás Luis Falzone
Aug 31, 2006·Journal of Neuroscience Research·Pascal Kienlen-CampardJean-Noël Octave
Dec 3, 2008·The European Journal of Neuroscience·Shengchun LiuWeihong Song
Jul 14, 2010·FEMS Yeast Research·Prashant BharadwajIan Macreadie
Mar 7, 2006·The Journal of Biological Chemistry·Kenneth M RosenHenry W Querfurth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.